These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 8542958

  • 1. Cytokine mobilization of peripheral blood stem cells in patients with Gaucher disease with a view to gene therapy.
    Nimgaonkar M, Mierski J, Beeler M, Kemp A, Lancia J, Mannion-Henderson J, Mohney T, Bahnson A, Rice E, Ball ED.
    Exp Hematol; 1995 Dec; 23(14):1633-41. PubMed ID: 8542958
    [Abstract] [Full Text] [Related]

  • 2. The presence of an autologous marrow stromal cell layer increases glucocerebrosidase gene transduction of long-term culture initiating cells (LTCICs) from the bone marrow of a patient with Gaucher disease.
    Wells S, Malik P, Pensiero M, Kohn DB, Nolta JA.
    Gene Ther; 1995 Oct; 2(8):512-20. PubMed ID: 8593601
    [Abstract] [Full Text] [Related]

  • 3. Transduction of mobilized peripheral blood CD34+ cells with the glucocerebrosidase cDNA.
    Nimgaonkar MT, Bahnson AB, Boggs SS, Ball ED, Barranger JA.
    Gene Ther; 1994 May; 1(3):201-7. PubMed ID: 7584082
    [Abstract] [Full Text] [Related]

  • 4. Comparison of retroviral transduction efficiency in CD34+ cells derived from bone marrow versus G-CSF-mobilized or G-CSF plus stem cell factor-mobilized peripheral blood in nonhuman primates.
    Hematti P, Tuchman S, Larochelle A, Metzger ME, Donahue RE, Tisdale JF.
    Stem Cells; 2004 May; 22(6):1062-9. PubMed ID: 15536196
    [Abstract] [Full Text] [Related]

  • 5. Efficient retroviral mediated transfer of the glucocerebrosidase gene in CD34+ enriched umbilical cord blood human hematopoietic progenitors.
    Mannion-Henderson J, Kemp A, Mohney T, Nimgaonkar M, Lancia J, Beeler MT, Mierski J, Bahnson AB, Ball ED, Barranger JA.
    Exp Hematol; 1995 Dec; 23(14):1628-32. PubMed ID: 8542957
    [Abstract] [Full Text] [Related]

  • 6. Correction of the enzyme deficiency in hematopoietic cells of Gaucher patients using a clinically acceptable retroviral supernatant transduction protocol.
    Xu L, Stahl SK, Dave HP, Schiffmann R, Correll PH, Kessler S, Karlsson S.
    Exp Hematol; 1994 Feb; 22(2):223-30. PubMed ID: 8299741
    [Abstract] [Full Text] [Related]

  • 7. Paclitaxel chemotherapy after autologous stem-cell transplantation and engraftment of hematopoietic cells transduced with a retrovirus containing the multidrug resistance complementary DNA (MDR1) in metastatic breast cancer patients.
    Cowan KH, Moscow JA, Huang H, Zujewski JA, O'Shaughnessy J, Sorrentino B, Hines K, Carter C, Schneider E, Cusack G, Noone M, Dunbar C, Steinberg S, Wilson W, Goldspiel B, Read EJ, Leitman SF, McDonagh K, Chow C, Abati A, Chiang Y, Chang YN, Gottesman MM, Pastan I, Nienhuis A.
    Clin Cancer Res; 1999 Jul; 5(7):1619-28. PubMed ID: 10430060
    [Abstract] [Full Text] [Related]

  • 8. Transduction of CD34+ enriched cord blood and Gaucher bone marrow cells by a retroviral vector carrying the glucocerebrosidase gene.
    Bahnson AB, Nimgaonkar M, Fei Y, Boggs SS, Robbins PD, Ohashi T, Dunigan J, Li J, Ball ED, Barranger JA.
    Gene Ther; 1994 May; 1(3):176-84. PubMed ID: 7584079
    [Abstract] [Full Text] [Related]

  • 9. Comparison between bone marrow and G-CSF-mobilized peripheral blood allografts undergoing clinical scale CD34+ cell selection.
    Hassan HT, Zeller W, Stockschläder M, Krüger W, Hoffknecht MM, Zander AR.
    Stem Cells; 1996 Jul; 14(4):419-29. PubMed ID: 8843543
    [Abstract] [Full Text] [Related]

  • 10. Retroviral transfer of the glucocerebrosidase gene into CD34+ cells from patients with Gaucher disease: in vivo detection of transduced cells without myeloablation.
    Dunbar CE, Kohn DB, Schiffmann R, Barton NW, Nolta JA, Esplin JA, Pensiero M, Long Z, Lockey C, Emmons RV, Csik S, Leitman S, Krebs CB, Carter C, Brady RO, Karlsson S.
    Hum Gene Ther; 1998 Nov 20; 9(17):2629-40. PubMed ID: 9853529
    [Abstract] [Full Text] [Related]

  • 11. The role of granulocyte colony-stimulating factor in mobilization and transplantation of peripheral blood progenitor and stem cells .
    Haas R, Murea S.
    Cytokines Mol Ther; 1995 Dec 20; 1(4):249-70. PubMed ID: 9384679
    [Abstract] [Full Text] [Related]

  • 12. CD34+ cells mobilized by cyclophosphamide and granulocyte colony-stimulating factor (G-CSF) are functionally different from CD34+ cells mobilized by G-CSF.
    Cesana C, Carlo-Stella C, Regazzi E, Garau D, Sammarelli G, Caramatti C, Tabilio A, Mangoni L, Rizzoli V.
    Bone Marrow Transplant; 1998 Mar 20; 21(6):561-8. PubMed ID: 9543059
    [Abstract] [Full Text] [Related]

  • 13. Persistent low-level engraftment of rhesus peripheral blood progenitor cells transduced with the fanconi anemia C gene after conditioning with low-dose irradiation.
    Kang EM, Hanazano Y, Frare P, Vanin EF, De Witte M, Metzger M, Liu JM, Tisdale JF.
    Mol Ther; 2001 Jun 20; 3(6):911-9. PubMed ID: 11407905
    [Abstract] [Full Text] [Related]

  • 14. Transduction of CD34-enriched human peripheral and umbilical cord blood progenitors using a retroviral vector with the Fanconi anemia group C gene.
    Walsh CE, Mann MM, Emmons RV, Wang S, Liu JM.
    J Investig Med; 1995 Aug 20; 43(4):379-85. PubMed ID: 7552587
    [Abstract] [Full Text] [Related]

  • 15. Pegylated granulocyte colony-stimulating factor mobilizes CD34+ cells with different stem and progenitor subsets and distinct functional properties in comparison with unconjugated granulocyte colony-stimulating factor.
    Bruns I, Steidl U, Fischer JC, Czibere A, Kobbe G, Raschke S, Singh R, Fenk R, Rosskopf M, Pechtel S, von Haeseler A, Wernet P, Tenen DG, Haas R, Kronenwett R.
    Haematologica; 2008 Mar 20; 93(3):347-55. PubMed ID: 18268278
    [Abstract] [Full Text] [Related]

  • 16. Efficient transduction and engraftment of G-CSF-mobilized peripheral blood CD34+ cells in nonhuman primates using GALV-pseudotyped gammaretroviral vectors.
    Beard BC, Mezquita P, Morris JC, Kiem HP.
    Mol Ther; 2006 Aug 20; 14(2):212-7. PubMed ID: 16631413
    [Abstract] [Full Text] [Related]

  • 17. Long-term follow-up of gene-marked CD34+ cells after autologous stem cell transplantation for multiple myeloma.
    Alici E, Björkstrand B, Treschow A, Aints A, Smith CI, Gahrton G, Dilber MS.
    Cancer Gene Ther; 2007 Mar 20; 14(3):227-32. PubMed ID: 17082794
    [Abstract] [Full Text] [Related]

  • 18. Collection of peripheral blood progenitor cells for autografting with low-dose cyclophosphamide plus granulocyte colony-stimulating factor.
    Bellido M, Sureda A, Martino R, Madoz P, García J, Brunet S.
    Haematologica; 1998 May 20; 83(5):428-31. PubMed ID: 9658727
    [Abstract] [Full Text] [Related]

  • 19. Successful collection and transplantation of peripheral blood stem cells in cancer patients using large-volume leukaphereses.
    Murea S, Goldschmidt H, Hahn U, Pförsich M, Moos M, Haas R.
    J Clin Apher; 1996 May 20; 11(4):185-94. PubMed ID: 8986864
    [Abstract] [Full Text] [Related]

  • 20. Mobilization, harvesting and selection of peripheral blood stem cells in patients with autoimmune diseases undergoing autologous hematopoietic stem cell transplantation.
    Statkute L, Verda L, Oyama Y, Traynor A, Villa M, Shook T, Clifton R, Jovanovic B, Satkus J, Loh Y, Quigley K, Yaung K, Gonda E, Krosnjar N, Spahovic D, Burt RK.
    Bone Marrow Transplant; 2007 Mar 20; 39(6):317-29. PubMed ID: 17277794
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.